Clinical Trials Directory

Trials / Unknown

UnknownNCT06049498

Trial of Mongolian Medicine ZhenBao Pills for Upper-limb Dysfunction After Stroke

Efficacy and Safety of Mongolian Medicine ZhenBao Pills on Limb Function Recovery After Acute Ischemic Stroke: a Randomized Double-blinded Placebo-controlled Trial.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
216 (estimated)
Sponsor
Dongzhimen Hospital, Beijing · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The trial was designed to test the hypothesis that treatment with Mongolian Medicine ZhenBao Pills has a positive effect on upper-limb motor recovery after acute ischemic stroke.

Detailed description

The study is a randomized, double-blinded, placebo-controlled, multi-center trial.

Conditions

Interventions

TypeNameDescription
DRUGMongolian Medicine ZhenBao PillsMongolian Medicine ZhenBao Pills, orally, 15 pills each time, twice a day.
DRUGMongolian Medicine ZhenBao Pills PlaceboMongolian Medicine ZhenBao Pills placebo, orally, 15 pills each time, twice a day.

Timeline

Start date
2023-10-01
Primary completion
2025-10-31
Completion
2025-12-31
First posted
2023-09-22
Last updated
2023-09-22

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06049498. Inclusion in this directory is not an endorsement.

Trial of Mongolian Medicine ZhenBao Pills for Upper-limb Dysfunction After Stroke (NCT06049498) · Clinical Trials Directory